Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Nov 06, 2023 11:22am
166 Views
Post# 35719442

RE:RE:RE:RE:Excellent News

RE:RE:RE:RE:Excellent NewsThanks Rhodium. I guess they are struggling to fill the minimum then.  This close and yet so far. At this point, I'm considering any kind of returns on this stock as a lucky lottery ticket, with a self reminder to never again invest in any Canadian startups without a lot more DD. SesenBio, Titan Medical, Sona Nanotech and a few others that i took a chance on. All great ideas. That's where it stopped. 
rhodiumd wrote: It wasn't an official NR. 

Theralase sent out an email blast to their newsletter subscriber list earlier this morning . They basically sent the same content that was released via NR a couple weeks ago.

Sign up to their newsletter on their website to receive the next ones.


<< Previous
Bullboard Posts
Next >>